Leerink Partners Reiterates Outperform Rating on Tenaya Therapeutics Inc (TNYA): "remains on track to share interim data"

March 12, 2026 10:37 AM

Leerink Partners analyst Mani Foroohar reiterated an Outperform rating and $2.00 price target on Tenaya Therapeutics Inc (NASDAQ: TNYA)The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found